Unity Biotechnology (UBX) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free UBX Stock Alerts $1.50 +0.02 (+1.35%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Unity Biotechnology Stock Price Performance5 Day Performance+1.35%1 Month Performance-7.98%3 Month Performance-11.76%6 Month Performance-17.58%Year-To-Date Performance-22.28%1 Year Performance-27.54% Receive UBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. UBX Stock Chart for Saturday, April, 27, 2024 UBX Chart by TradingView Unity Biotechnology Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$1.48$1.50+1.35%$1.52$1.4738,503 shs$25.19 million04/25/2024$1.47$1.48+0.68%$1.49$1.4616,871 shs$24.85 million04/24/2024$1.49$1.47-1.34%$1.50$1.4681,943 shs$24.68 million04/23/2024$1.48$1.49+0.68%$1.50$1.4736,550 shs$25.02 million04/22/2024$1.50$1.48-1.33%$1.52$1.4771,884 shs$24.85 million04/19/2024$1.51$1.50-0.66%$1.52$1.5045,187 shs$25.19 million Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$1.51$1.51+0.33%$1.54$1.5027,572 shs$25.35 million04/17/2024$1.52$1.51-0.99%$1.52$1.5028,480 shs$25.25 million04/16/2024$1.50$1.52+1.33%$1.52$1.5059,254 shs$25.51 million04/15/2024$1.52$1.50-1.32%$1.55$1.5034,074 shs$25.18 million04/12/2024$1.50$1.52+1.33%$1.52$1.5087,319 shs$25.51 million04/11/2024$1.51$1.50-0.66%$1.52$1.5026,223 shs$25.18 million04/10/2024$1.55$1.51-2.58%$1.60$1.50147,512 shs$25.34 million04/09/2024$1.56$1.55-0.64%$1.59$1.5159,315 shs$26.01 million04/08/2024$1.57$1.56-0.64%$1.60$1.5547,862 shs$26.18 million04/05/2024$1.57$1.57$1.60$1.52109,064 shs$26.35 million04/04/2024$1.58$1.57-0.63%$1.63$1.5637,015 shs$26.35 million04/03/2024$1.61$1.58-1.86%$1.61$1.5649,369 shs$26.51 million04/02/2024$1.66$1.61-3.01%$1.66$1.5857,429 shs$27.02 million04/01/2024$1.64$1.66+1.22%$1.66$1.6068,083 shs$27.86 million03/29/2024$1.64$1.64$1.66$1.5865,620 shs$27.52 million03/28/2024$1.63$1.64+0.61%$1.66$1.5865,620 shs$27.52 million03/27/2024$1.62$1.63+0.62%$1.65$1.6234,457 shs$27.35 million03/26/2024$1.58$1.62+2.53%$1.62$1.5844,371 shs$27.19 million03/25/2024$1.57$1.58+0.64%$1.63$1.5571,295 shs$26.51 million03/22/2024$1.53$1.57+2.61%$1.57$1.5244,304 shs$26.35 million03/21/2024$1.57$1.53-2.55%$1.60$1.5257,047 shs$25.68 million03/20/2024$1.50$1.57+4.67%$1.58$1.5035,499 shs$26.35 million03/19/2024$1.50$1.50$1.54$1.5044,897 shs$25.17 million03/18/2024$1.50$1.50$1.58$1.5052,499 shs$25.17 million03/15/2024$1.50$1.50$1.58$1.50161,894 shs$25.17 million03/14/2024$1.52$1.50-1.32%$1.58$1.5060,629 shs$25.17 million03/13/2024$1.55$1.52-1.94%$1.58$1.5199,555 shs$25.51 million03/12/2024$1.59$1.55-2.52%$1.61$1.5596,547 shs$26.02 million03/11/2024$1.57$1.59+1.27%$1.65$1.5470,333 shs$26.68 million03/08/2024$1.65$1.57-4.85%$1.69$1.50229,495 shs$26.35 million03/07/2024$1.66$1.65-0.60%$1.69$1.6274,422 shs$27.70 million03/06/2024$1.66$1.66$1.69$1.61109,140 shs$27.86 million03/05/2024$1.64$1.66+1.22%$1.70$1.58239,134 shs$27.86 million03/04/2024$1.80$1.64-8.89%$1.83$1.63195,209 shs$27.52 millionThese AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy03/01/2024$1.83$1.80-1.64%$1.94$1.74349,605 shs$30.20 million02/29/2024$1.71$1.83+7.02%$1.89$1.70298,494 shs$30.71 million02/28/2024$1.83$1.71-6.56%$1.84$1.55656,069 shs$28.69 million02/27/2024$1.87$1.83-2.14%$1.92$1.8355,535 shs$30.72 million02/26/2024$1.80$1.87+3.89%$1.88$1.7754,008 shs$31.38 million02/23/2024$1.79$1.80+0.56%$1.82$1.7458,500 shs$30.20 million02/22/2024$1.75$1.79+2.29%$1.80$1.7435,532 shs$30.05 million02/21/2024$1.83$1.75-4.37%$1.89$1.70102,109 shs$29.37 million02/20/2024$1.95$1.83-6.15%$1.99$1.7984,355 shs$30.71 million02/19/2024$1.95$1.95$2.02$1.9379,600 shs$32.72 million02/16/2024$1.99$1.95-2.01%$2.02$1.9379,605 shs$32.72 million02/15/2024$1.93$1.99+3.38%$2.00$1.9278,761 shs$33.39 million02/14/2024$1.87$1.93+2.94%$1.98$1.8874,048 shs$32.30 million02/13/2024$1.80$1.87+3.89%$1.95$1.76171,251 shs$31.38 million02/12/2024$1.79$1.80+0.56%$1.95$1.75100,182 shs$30.21 million02/09/2024$1.76$1.79+1.70%$1.83$1.7436,710 shs$30.04 million02/08/2024$1.72$1.76+2.33%$1.95$1.6996,014 shs$29.53 million02/07/2024$1.73$1.72-0.58%$1.75$1.7124,290 shs$28.86 million02/06/2024$1.68$1.73+2.98%$1.74$1.6870,635 shs$29.03 million02/05/2024$1.76$1.68-4.55%$1.75$1.6855,453 shs$28.19 million02/02/2024$1.76$1.76$1.77$1.7131,532 shs$29.53 million02/01/2024$1.73$1.76+1.73%$1.78$1.7153,610 shs$29.53 million01/31/2024$1.67$1.73+3.59%$1.77$1.6834,597 shs$29.03 million01/30/2024$1.75$1.67-4.57%$1.77$1.6756,165 shs$28.02 million01/29/2024$1.70$1.75+2.94%$1.79$1.7153,810 shs$29.37 million01/26/2024$1.70$1.70$1.75$1.6750,889 shs$28.53 million Related Companies: Acurx Pharmaceuticals Stock Chart Aileron Therapeutics Stock Chart Eyenovia Stock Chart Sensei Biotherapeutics Stock Chart Sol-Gel Technologies Stock Chart Forte Biosciences Stock Chart DURECT Stock Chart Enlivex Therapeutics Stock Chart Addex Therapeutics Stock Chart Lisata Therapeutics Stock Chart Receive UBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Unity Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UBX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.